Trial no.:
|
PACTR201806003444426 |
Date of Approval:
|
02/06/2018 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Analgesic effect of dexmedetimodine: Topical versus intravenous for pediatric tonsillectomy. |
Official scientific title |
Analgesic effect of dexmedetimodine: Topical versus intravenous for pediatric tonsillectomy. |
Brief summary describing the background
and objectives of the trial
|
Dexmedetimodine is an alpha2-adrenergic agonist, exhibits analgesic and anti inflammatory effects in the perioperative period. Early benefit (< 48h) of systemic Dexmedetimodine is controversed after pediatric tonsillectomy while topical Dexmedetimodine application on tonsillar bed may enhances pain relief . This study evaluates the benefit of systemic Dexmedetimodine administration and questions the topical effect. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Ear, Nose and Throat,Paediatrics,pot tonsillectomy pain.,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
07/06/2018 |
Actual trial start date |
|
Anticipated date of last follow up |
30/08/2018 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
326 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|